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Abstract 
After reading this article, the learner should be able to: • Describe the importance of dosage 
administration aids as a way to help improve medication compliance and therapeutic outcomes, as well 
as averting potential adverse drug events; • Identify the benefits of good communication between 
pharmacists, prescribing doctors and, when appropriate, hospital and/or aged care facility staff for the 
timely packaging, dispensing and administration of the correct medications in dosage administration 
aids. 
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Blister-packed medications: 
improving compliance and reducing adverse events
Background
People aged 65 years and older 
make up more than 13% (approx 2.7 
million) of the Australian population.1 
Furthermore, 25% of this older cohort 
take an average of 4.5 medications 
concurrently.2 Despite the fact that 
failing to follow recommended 
medication regimens results in poor 
health outcomes,3 between 40% and 
60% of older people are not taking 
their medications as prescribed.4 
According to the Australian Bureau of 
Statistics (ABS) in 2006, more than 90% 
older Australians suffered from one or 
several (acute or chronic) illnesses for 
which they took different medications 
concurrently.5
In Australia, 6% of the people aged 
65 years and older and more than 26% 
of those aged 85 years and older live 
in non-private dwellings, hostels and 
residential aged care facilities (RACFs).2 
Importantly, just over 40% of the care 
facility residents have been diagnosed 
with some level of capacity impairment 
such as impaired cognitive states, 
Alzheimer’s disease or some form 
of dementia6 and are prescribed an 
average of seven medications daily.7,8 
It is estimated that an individual’s 
inability to manage their medications 
accounts for 23% of admissions into 
residential aged care facilities.4
The use of dose administration 
aids (DAAs) can be used to improve 
medication compliance, especially 
among people with age related 
cognitive and physical impairments 
and poor health literacy skills.4,9 
Pharmacists, by advocating the 
use of DAAs and through their 
increased professional care and 
services, are well placed to help 
improve patient compliance, thus 
affording older people the luxury of 
remaining domiciled in their own 
homes and reducing the demand 
for RACF placements based on poor 
medication management. 
Currently the Department of 
Health and Ageing and the Pharmacy 
Guild of Australia are staging the DAA 
Program to develop the broader use of 
government-sponsored DAA services 
within the community. The Quality 
Care Pharmacy Program (QCPP) offers 
a system of voluntary accreditation 
of pharmacies that comply with 
professional standards including 
comprehensive DAAs guidelines and 
standards, dispensing standards and 
counselling standards. It is timely 
therefore that pharmacists recognise, 
understand and make contingencies 
to mitigate against the many factors 
that negatively affect drug compliance 
in older people. As the community 
ages and as DAAs become more 
prevalent pharmacists roles will 
change, with greater time and 
attention being required in educating 
patients/carers, communicating with 
other healthcare professionals and 
acting as patient advocates when non 
compliance is an issue or to avoid 
adverse drug events (ADEs). 
With this background, the ‘Blister 
Packed Medication use Amongst 
Pharmacies in the Illawarra Region’ 
study was undertaken. The aims and 
objectives of the study were as follows:
1. to gain an understanding of the 
extent to which blister-packed 
medications are used in the Illawarra;
2.  to investigate the efficiency of DAAs; 
3.  to investigate the reasons why DAAs 
are supplied in the Illawarra.
Methodology
Following ethics approval from the 
University of Wollongong Human 
Ethics Committee, a written survey was 
sent by mail and/or in person to the 55 
licensed Illawarra-based community 
pharmacies between December 2007 
and February 2008. The surveys were 
completed on a voluntary basis by 
community pharmacy personnel and 
sent back to the researchers. 
Quantitative data from the survey 
was analysed using descriptive 
statistical analysis, while qualitative 
data was thematically analysed. The 
survey tool used for data collection 
purposes had been specifically 
developed for this study and had 
not been previously validated. Some 
questions within the tool, however, 
had been derived from the Dose 
Administration Aids (DAA) Program 
registration form (2008), while other 
questions related to information 
about the numbers of patients 
receiving blister packs, the number of 
medications per blister pack and the 
impact of the provision of blister pack 
services on pharmacy workloads.
results
Forty one of the 55 pharmacies (74.5%) 
completed the survey questionnaire 
and responded that during the time of 
the study they packaged medication 
blister packs or DAAs for 2,549 Illawarra 
residents, 2,261 (88.7%) of whom 
were aged 65 years and older. The 
pharmacists suggested that that the 
most common reason for being asked 
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to provide a DAA was because of the 
patient’s complex medication regimen, 
followed by patient forgetfulness 
and/or cognitive impairments such 
as dementia/Alzheimer’s disease. 
Importantly, the pharmacists stated 
that in the majority of cases they had 
initially recommended the use of the 
DAA to either the patient and/or their 
carer or alternatively the patient’s 
general practitioner had done so.
Based on the survey questions 
regarding the return of the DAAs 
(ie. blister packs returned to the 
pharmacy for repackaging), 77.7% of 
the pharmacy respondents said that 
blister packs were returned having 
been used correctly (> 75% of the 
medications had been removed 
correctly), 16.49% somewhat 
correctly (25–75% of medications 
removed), and 5.94% had not been 
used correctly (< 25% 0f medications 
removed). The survey respondents 
also suggested that an overwhelming 
98.6% of DAAs returned for residents 
of RACFs had been used correctly.
Just over 50% of the pharmacy 
respondents suggested that 
communications about medication 
changes (eg. warfarin doses) requiring 
repackaging, between themselves and 
GPs was ‘good’; 25% of them rated 
this communication exchange as 
‘average’; and a further 25% suggested 
that it was ‘below average’. Similarly, 
communication about medication 
changes between pharmacies and the 
22 RACFs provided with DAAs was 
deemed to be ‘good’ for 45.5% of the 
respondents, ‘average’ for 36.4% and 
‘below average’ for 19.6%. 
The efficiency of their individual 
pharmacy processes for dealing with 
these recommended medication 
changes were also rated by 
respondents, with 22.5% rating them 
as ‘excellent’, 57.5% rating them 
as ‘good’, and 20% rating them as 
‘average’ or ‘below average’. 
Finally, respondents were asked to 
rate the impact of changes to blister 
pack medications on the workload 
of the pharmacy staff. Some 48.6% 
of respondents rated the impact as 
between ‘very heavy’ and ‘heavy’, while 
the remaining 51.4% rated changes 
as only having a ‘moderate’ to ‘slight 
impact’ on their workload. 
Some of the other findings of the 
study included comments about 
the efficiency of the DAA packaging 
and dispensing being heavily 
reliant on good communication 
between the pharmacist and the GP. 
Respondents also commented on 
poor communication from hospitals 
to GPs and pharmacists about changes 
to medications regimens which are 
made for patients discharged from 
hospital. This poor communication 
they felt impeded the correct and 
timely packaging, dispensing and 
administration of post-discharge 
medications in DAAs.
Discussion 
Evidence suggests that poor 
medication compliance, especially 
among older people suffering from 
co-morbidities and taking several 
different medications (polypharmacy), 
increases the likelihood of ADEs.10,11 
Good medication compliance is one 
of the key strategies that can be used 
to improve therapeutic outcomes 
and reduce the incidence of ADEs.12,13 
This study suggests that medication 
compliance can be improved by 
providing DAAs for patients generally, 
but in particular older patients with 
complex medication regimens and 
cognitive and/or physical decline, living 
in both community and residential 
aged care settings.
Good communication between the 
pharmacies providing the DAAs, the 
prescribing doctors and the residential 
aged care facility (for aged care 
residents) is a very important factor to 
facilitate timely packaging, dispensing 
and administration of the correct 
medications within a DAA. The hiatus 
in communication between hospital 
and community pharmacies regarding 
discharge patients’ medications was of 
concern to the pharmacists surveyed 
in the study. Their apprehensions 
represented a heightened perception 
of risk in dispensing errors, adverse 
drug reactions, and incorrect 
counselling of patients. A more 
streamlined, accurate and standard 
system of communication should 
therefore be installed to ensure 
the continuity of patient care after 
discharge from hospital. 
It is noteworthy that despite the 
imperfections of the current systems, 
despite the impost of blister pack 
changes on pharmacists’ workloads 
and despite the poor remuneration of 
pharmacists for the blister pack service, 
pharmacists are still willing to support 
and provide DAAs because they believe 
it is a worthwhile community service.
The Illawarra study found that 
approximately only 6% (2,261) of 
the almost 37,000 Illawarra residents 
aged 60 years and older were 
being provided with a DAA from an 
Illawarra-based pharmacy. It should 
be acknowledged that some patients 
could have been provided with a 
DAA from a pharmacy outside of the 
region, and others would not have 
required a DAA. 
It appears however, that the 
service is being grossly underutilised, 
especially considering the benefits 
that can be derived from such a 
service for ‘at risk’ patients with 
complex medications regimens 
and/or suffering from cognitive 
and/or physical impairments. One 
respondent suggested an awareness 
campaign to endorse and inform the 
public of the benefits of DAAs should 
be undertaken.
The Illawarra study, although 
limited in its scope, shows that there 
is undoubtedly a case for collective 
professional improvement of 
pharmacy practice in respect of DAAs 
with a view to improving patient 
compliance and reducing ADEs. Dylan 
was right, ‘For the times they are a 
changing’, and the profession must 
take heed.
conclusion
The Illawarra study is a snapshot of 
DAA usage which will continue to 
increase into the near future and 
provide considerable benefit to 
the community particularly with 
regard to increasing compliance 
rates, reducing ADEs and keeping 
people domiciled in their own homes 
for longer or for life. To that end 
pharmacists will continue to increase 
their professional role as educators 
and communicators, facilitating the 
medication management process and 
advocating on behalf of patients. 
Pharmacists are no longer simply 
dispensers or sellers of medicines. 
Hopefully in the not-too-distant 
future pharmacists will be recognised 
and remunerated justly for the 
professional role they play. 
Recommendations based on the 
study include: the investigation 
and standardisation of discharge 
procedures with emphasis on the 
continuity of care; the introduction 
of a nation-wide database to 
limit adverse outcomes due to 
polypharmacy and the continued 
education of all medical personnel 
involved in the continuity of 
patient care.
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